Cargando…
Integrating longitudinal serum IL-17 and IL-23 follow-up, along with autoantibodies variation, contributes to predict bullous pemphigoid outcome
Bullous pemphigoid (BP) is an inflammatory autoimmune bullous disease involving cytokines and proteases in the process of blister formation. Recently, IL-17 and IL-23 were evidenced in lesional skin and serum of BP patients at time of diagnosis, but their involvement in disease outcome has still not...
Autores principales: | Plée, Julie, Le Jan, Sébastien, Giustiniani, Jérôme, Barbe, Coralie, Joly, Pascal, Bedane, Christophe, Vabres, Pierre, Truchetet, François, Aubin, François, Antonicelli, Frank, Bernard, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677293/ https://www.ncbi.nlm.nih.gov/pubmed/26656739 http://dx.doi.org/10.1038/srep18001 |
Ejemplares similares
-
IL-23/IL-17 Axis Activates IL-1β-Associated Inflammasome in Macrophages and Generates an Auto-Inflammatory Response in a Subgroup of Patients With Bullous Pemphigoid
por: Le Jan, Sébastien, et al.
Publicado: (2019) -
Innate immune cell-produced IL-17 sustains inflammation in bullous pemphigoid
por: Le Jan, S., et al.
Publicado: (2014) -
NET Formation in Bullous Pemphigoid Patients With Relapse Is Modulated by IL-17 and IL-23 Interplay
por: Giusti, Delphine, et al.
Publicado: (2019) -
Mucosal Involvement in Bullous Pemphigoid Is Mostly Associated with Disease Severity and to Absence of Anti-BP230 Autoantibody
por: Clapé, Ariane, et al.
Publicado: (2018) -
Eosinophil Cationic Protein (ECP), a predictive marker of bullous pemphigoid severity and outcome
por: Giusti, Delphine, et al.
Publicado: (2017)